Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Tarih
2021Üst veri
Tüm öğe kaydını gösterÖzet
We appreciate the comments made by Dr. Bedel et al. NLR, PLR, and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Due to this, we have listed some of the dis-orders mentioned above in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were excluded from the study. However, the presence of malignancy did not affect our results in the regression analysis.
Kaynak
Bosnian Journal of Basic Medical SciencesCilt
21Sayı
4Aşağıdaki lisans dosyası bu öğe ile ilişkilidir: